Results 191 to 200 of about 145,694 (350)
Clinical effect of different methods on chronic pelvic inflammatory disease
Liu Kang-yan, Bin Wang, Luohu Women
openalex +1 more source
Analysis of Risk Factors for Surgical Treatment of Acute Female Pelvic Inflammatory Disease
Xuwei Chen +4 more
openalex +2 more sources
ABSTRACT Objective The real‐world evidence on the association between glucagon‐like peptide‐1 receptor agonists (GLP‐1RAs) and cancer risk remains limited and mixed. Methods In 2013–2020 national Medicare claims data, we included cancer‐naïve patients with type 2 diabetes (T2D). We identified those who initiated GLP‐1 RA, sodium‐glucose cotransporter 2
Ying Lu +13 more
wiley +1 more source
Cervicovaginal microbiome composition and absolute quantity are associated with pelvic inflammatory disease. [PDF]
Luu LDW +16 more
europepmc +1 more source
ABSTRACT Objective This study evaluated the association between antiobesity medications (AOM) and incident cardiovascular disease (CVD) among older women, examining this relationship within and across survivors of obesity‐related cancers (ORCa) and age‐matched cancer‐free populations.
David S. Lopez +10 more
wiley +1 more source
Clinical efficacy of levofloxacin hydrochloride plus metronidazole in the treatment of pelvic inflammatory disease: a retrospective analysis. [PDF]
Xue FF +5 more
europepmc +1 more source
Abstract Background Cauda equina syndrome is a surgical emergency often caused by lumbar disc herniation. Spinal manipulative therapy is commonly used for lumbar spine disorders, but case reports have raised concerns it may precipitate cauda equina syndrome. One cohort study suggested no increased risk, although it did not focus on patients with lumbar
Robert J. Trager +3 more
wiley +1 more source
Druggable Targets for Pelvic Inflammatory Disease: Mendelian Randomization and Experimental Validation. [PDF]
Dang C +6 more
europepmc +1 more source

